Donald Hooker

Stock Analyst at Keybanc

(2.49)
# 2,475
Out of 5,045 analysts
82
Total ratings
55.95%
Success rate
9.22%
Average return

Stocks Rated by Donald Hooker

Teladoc Health
Feb 23, 2022
Maintains: Overweight
Price Target: $180$100
Current: $8.74
Upside: +1,044.16%
Charles River Laboratories International
Feb 17, 2022
Maintains: Overweight
Price Target: $450$390
Current: $179.11
Upside: +117.74%
Quest Diagnostics
Dec 13, 2021
Maintains: Overweight
Price Target: $168$170
Current: $175.75
Upside: -3.27%
IQVIA Holdings
Nov 17, 2021
Maintains: Overweight
Price Target: $270$290
Current: $216.47
Upside: +33.97%
Phreesia
Jul 12, 2021
Maintains: Overweight
Price Target: $70$73
Current: $22.66
Upside: +222.15%
Recursion Pharmaceuticals
May 11, 2021
Initiates: Overweight
Price Target: $36
Current: $5.65
Upside: +537.17%
American Well
Apr 16, 2021
Initiates: Sector Weight
Price Target: n/a
Current: $5.15
Upside: -
Veeva Systems
Feb 17, 2021
Maintains: Overweight
Price Target: $332$353
Current: $285.03
Upside: +23.85%
HealthEquity
Dec 2, 2020
Downgrades: Sector Weight
Price Target: n/a
Current: $92.95
Upside: -
Maximus
Aug 7, 2020
Maintains: Overweight
Price Target: $80$84
Current: $83.47
Upside: +0.63%
Downgrades: Sector Weight
Price Target: n/a
Current: $6.60
Upside: -
Maintains: Overweight
Price Target: $212$170
Current: $252.33
Upside: -32.63%
Downgrades: Sector Weight
Price Target: n/a
Current: $165.33
Upside: -
Maintains: Overweight
Price Target: $68$46
Current: $1.40
Upside: +3,185.71%
Downgrades: Sector Weight
Price Target: n/a
Current: $28.14
Upside: -
Downgrades: Sector Weight
Price Target: n/a
Current: $580.37
Upside: -